Trimetazidine | search
Click here to view Trimetazidine news from 60+ newspapers.
Bookmark or Share- Trimetazidine - WikipediaTrimetazidine (IUPAC: 1-(2,3,4-trimethoxybenzyl)piperazine) is a drug sold under many brand names for angina pectoris (chest pain associated with impaired blood flow to the heart). Trimetazidine is described as the first cytoprotective anti-ischemic agent developed and marketed by Laboratoires Servier (France).
- What is Trimetazidine used for? - Drugs.comTrimetazidine is used to treat: Angina: chest pain that occurs when the heart doesn’t get enough oxygenated blood. Heart failure: when the heart doesn’t pump as well as it should. Peripheral artery disease (PAD): when there’s a narrowing of the blood vessels that take blood from the heart to the rest of the body.
- Trimetazidine Revisited: A Comprehensive Review of the ...Trimetazidine (TMZ) is an effective and well-tolerated antianginal drug that possesses protective properties against ischemia-induced heart injury. Growing interest in metabolic modulation in recent years urged an up-to-date review of the literature on TMZ.
- Trimetazidine: Uses, Interactions, Mechanism of Action ...Trimetazidine is a piperazine derivative indicated as an adjunct therapy in symptomatic treatment of stable angina pectoris.
- Trimetazidine in Practice: Review of the Clinical and ...Trimetazidine controls myocardial ischemia through intracellular metabolic changes and was found to be effective compared with placebo, alone, or combined with conventional antianginal agents.
More
